DuPont Nutrition & Biosciences (booth 966) will present 12 poster presentations AAPS PharmSci 360 addressing efficient and cost- saving solutions for taste-masking, abuse deterence, biologic stabilization and more. A few presentations relevant to everyday industry challenges include:

· Improving Powder Bed Wetting in Continuous Twin Screw Granulation via Foamed Systems, Monday, Nov. 4 at 9:30 a.m. CST, Kevin O’Donnell, R&D Manager, will introduce a newly developed wetting technology for twin screw granulation that will eliminate oversaturation, while reducing associated costs.

· Novel Surfactant Excipient Significantly Improves Biologic Stability in Liquid Formulation, Monday, Nov. 4, at 12:30 p.m. CST, Joshua Katz, Senior Principal Scientist and AAPS 2018 “Best Abstract” Award recipient, will share new research on improving the formulation stability of drugs to reduce manufacturing costs and eliminate potential patient side effects of instability.

· Taste-Masking Bitter Drugs with Ion Exchange Resin in Carrageenan Based Gummies, Wednesday, Nov. 6 at 10:30 a.m. CST, Amie Gehris, Technical Sales Representative, will discuss optimal taste-masking properties to conceal the bitter, seaweed taste associated with carrageenan-based gummies.

· Physical Property Testing of Gelatin and SeaGel® Films for Soft Capsule Applications, Wednesday, Nov. 6, at 12:30 p.m. CST, Rebecca Putans, Associate Research Chemist, will explore the performance benefits of SeaGel® as a vegetarian alternative to gelatin for soft capsule manufacturing.

Additional DuPont presentations will cover: liquid chromatography in microcrystIalline cellulose samples; polymer influences on rheology; abuse deterrent technology; hot melt extruded caffeine pellets; and disintegration of minitablets.

“We’re passionate about driving advancement within this ever-evolving industry, remaining forever curious about how to deliver today and will advance our customers into the future,” said Nick Grasman, America’s Marketing Manager, DuPont Nutrition & Biosciences. “Attending AAPS PharmSci 360 enables us to collaborate with customers and understand how our products and research can simplify and refine their specific drug formulation needs.”